Fairview Clinics
Fairview Clinics was paid $2.82M by Medicaid between Oct 2020 and Dec 2024, across 92 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 59% of everything it billed.
MINNEAPOLIS, MN 55407
Next to other Clinic/Center providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 5,932 | $213K | |
| 2021 | 23,256 | $934K | |
| 2022 | 14,431 | $606K | |
| 2023 | 11,660 | $559K | |
| 2024incomplete | 9,322 | $508K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 59% | 18,400 | 16,989 | $1.66M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 7,430 | 7,082 | $483K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.4% | 755 | 708 | $95K |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 12,446 | 11,703 | $62K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.7% | 3,812 | 3,690 | $49K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 553 | 542 | $49K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 1.4% | 651 | 640 | $41K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.0% | 668 | 243 | $29K |
| 80061 | Lipid panel | <1% | 1,899 | 1,842 | $25K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,388 | 2,345 | $23K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 224 | 212 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 825 | 808 | $15K |
80 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 432 | $14K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 197 | $14K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 444 | $12K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 234 | $12K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 432 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 1,036 | $11K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 105 | $11K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 665 | $10K |
| 90686 | <1% | 994 | $10K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 102 | $9K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 209 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 207 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 955 | $9K |
| 99460 | <1% | 121 | $8K | |
| 85027 | <1% | 1,081 | $7K | |
| 86803 | <1% | 435 | $7K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 73 | $7K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 60 | $6K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 42 | $6K |
| 91320 | <1% | 66 | $6K | |
| 90662 | <1% | 92 | $5K | |
| 82728 | <1% | 283 | $4K | |
| 86780 | <1% | 231 | $3K | |
| 81025 | <1% | 350 | $3K | |
| 92551 | <1% | 418 | $3K | |
| 90682 | <1% | 63 | $3K | |
| 0054A | <1% | 76 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 30 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 335 | $3K |
| 90480 | <1% | 79 | $3K | |
| 90651 | <1% | 25 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 28 | $3K |
| 90715 | <1% | 98 | $2K | |
| 0004A | <1% | 63 | $2K | |
| 0052A | <1% | 56 | $2K | |
| 99000 | <1% | 187 | $2K | |
| 82043 | <1% | 343 | $2K | |
| 0001A | <1% | 103 | $2K | |
| 80306 | <1% | 112 | $2K | |
| 99188 | <1% | 190 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 39 | $2K |
| 99223 | Prolong inpt eval add15 m | <1% | 15 | $2K |
| 90670 | <1% | 193 | $2K | |
| 0064A | <1% | 44 | $2K | |
| 96127 | <1% | 326 | $1K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 30 | $1K |
| 0051A | <1% | 33 | $1K | |
| 99443 | <1% | 18 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 104 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 133 | $1K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 254 | $1K |
| 0031A | <1% | 22 | $880.22 | |
| 0002A | <1% | 31 | $842.71 | |
| 81001 | <1% | 245 | $841.76 | |
| 81003 | <1% | 327 | $797.42 | |
| 90656 | <1% | 64 | $784.48 | |
| 99173 | <1% | 430 | $740.59 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 30 | $680.59 |
| 85018 | <1% | 246 | $627.32 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 82 | $582.39 |
| 0072A | <1% | 13 | $547.15 | |
| 86706 | <1% | 42 | $517.29 | |
| 0071A | <1% | 12 | $508.37 | |
| 87210 | <1% | 76 | $499.93 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $482.28 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 15 | $455.25 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 39 | $395.60 |
| 87338 | <1% | 24 | $379.67 | |
| 36416 | <1% | 105 | $349.04 | |
| 83540 | <1% | 42 | $310.16 | |
| 96161 | <1% | 136 | $246.45 | |
| 82607 | <1% | 12 | $204.96 | |
| 82947 | <1% | 36 | $161.70 | |
| 87340 | <1% | 13 | $153.97 | |
| 84439 | <1% | 13 | $134.58 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 20 | $121.18 |
| 86140 | <1% | 13 | $71.11 | |
| 82570 | <1% | 16 | $0.15 | |
| 90723 | 0% | 70 | $0.00 | |
| 90648 | 0% | 123 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.